A detailed history of Relyea Zuckerberg Hanson LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Relyea Zuckerberg Hanson LLC holds 4,596 shares of BMY stock, worth $263,488. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,596
Holding current value
$263,488
% of portfolio
0.04%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$39.66 - $51.75 $182,277 - $237,843
4,596 New
4,596 $237,000
Q4 2023

Oct 31, 2024

BUY
$48.48 - $57.85 $29,281 - $34,941
604 Added 11.16%
6,015 $308,000
Q4 2023

Jan 18, 2024

BUY
$48.48 - $57.85 $29,281 - $34,941
604 Added 11.16%
6,015 $308,000
Q3 2023

Oct 31, 2024

BUY
$57.89 - $64.73 $47,180 - $52,754
815 Added 17.73%
5,411 $314,000
Q3 2023

Oct 16, 2023

SELL
$57.89 - $64.73 $57,426 - $64,212
-992 Reduced 15.49%
5,411 $314,000
Q2 2023

Jul 17, 2023

BUY
$63.71 - $70.74 $128,885 - $143,107
2,023 Added 46.19%
6,403 $409,000
Q1 2023

Apr 18, 2023

SELL
$65.71 - $74.53 $17,478 - $19,824
-266 Reduced 5.73%
4,380 $303,000
Q4 2022

Jan 18, 2023

BUY
$68.48 - $81.09 $55,194 - $65,358
806 Added 20.99%
4,646 $0
Q3 2022

Nov 02, 2022

BUY
$0.13 - $76.84 $5 - $3,380
44 Added 1.16%
3,840 $273,000
Q2 2022

Jul 18, 2022

BUY
$72.62 - $79.98 $46,767 - $51,507
644 Added 20.43%
3,796 $292,000
Q1 2022

Apr 19, 2022

SELL
$61.48 - $73.72 $127,755 - $153,190
-2,078 Reduced 39.73%
3,152 $242,000
Q4 2021

Jan 14, 2022

BUY
$53.63 - $62.52 $280,484 - $326,979
5,230 New
5,230 $324,000
Q3 2021

Oct 22, 2021

SELL
$59.17 - $69.31 $224,490 - $262,962
-3,794 Closed
0 $0
Q2 2021

Jul 23, 2021

BUY
$61.91 - $67.42 $234,886 - $255,791
3,794 New
3,794 $254,000
Q1 2021

Apr 29, 2021

SELL
$59.34 - $66.74 $310,348 - $349,050
-5,230 Closed
0 $0
Q4 2020

Jan 28, 2021

SELL
$57.74 - $65.43 $2,887 - $3,271
-50 Reduced 0.95%
5,230 $324,000
Q3 2020

Oct 16, 2020

SELL
$57.43 - $63.64 $95,506 - $105,833
-1,663 Reduced 23.95%
5,280 $318,000
Q2 2020

Jul 13, 2020

SELL
$54.82 - $64.09 $24,943 - $29,160
-455 Reduced 6.15%
6,943 $408,000
Q4 2019

Jan 15, 2020

BUY
$49.21 - $64.19 $364,055 - $474,877
7,398 New
7,398 $475,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Relyea Zuckerberg Hanson LLC Portfolio

Follow Relyea Zuckerberg Hanson LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Relyea Zuckerberg Hanson LLC, based on Form 13F filings with the SEC.

News

Stay updated on Relyea Zuckerberg Hanson LLC with notifications on news.